HCW Biologics Inc.
HCWB
$7.77
$0.7210.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.56% | 74.46% | -104.61% | 30.08% | -116.27% |
| Total Depreciation and Amortization | 431.54% | -1.15% | -46.65% | -11.33% | -1.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.69% | -3.09% | -1.84% | -95.57% | 2,985.44% |
| Change in Net Operating Assets | -170.94% | -93.88% | 197.60% | 237.47% | 190.40% |
| Cash from Operations | 3.13% | 39.81% | -34.91% | 7.47% | 30.32% |
| Capital Expenditure | -205.66% | -299.46% | 114.34% | 96.51% | -489.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -205.66% | -299.46% | 114.34% | 96.51% | -139.66% |
| Total Debt Issued | -86.75% | 45.13% | 11.43% | -- | -- |
| Total Debt Repaid | -4.73% | -1.72% | 2.02% | -1.37% | -225.56% |
| Issuance of Common Stock | -- | -- | -100.00% | 17,773.57% | 13,900.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 136.56% | 45.79% | -54.51% | 27,698.69% | -71.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,354.08% | 94.42% | -697.71% | 106.41% | -302.18% |